Centocor
This article was originally published in The Gray Sheet
Executive Summary
Names Stephen Hayter, 53, as head of the firm's diagnostics division and a corporate executive vice president. Hayter succeeds David Holveck, who was promoted to president of Centocor last April and to CEO in November ("The Gray Sheet" Nov. 9, 1992, In Brief). Most recently, Hayter was an executive vice president of Worcester, Massachusetts- based Cambridge Biotech and general manager of its diagnostics division.